Worthley 2003.
Clinical features and settings |
Clinical features
Setting
|
|
Participants |
Exclusion criteria
|
|
Study design | Cohort study | |
Target condition and reference standard(s) |
Coronary artery stenosis measured by coronary angiography
|
|
Index and comparator tests |
Tachycardic‐stress perfusion imaging
|
|
Follow‐up | Mean follow‐up of 28 ± 10 months. | |
Notes | Informed consent was obtained before study entry. | |
Table of Methodological Quality | ||
Item | Authors' judgement | Description |
Representative spectrum? All tests | Yes | ESKD patients undergoing cardiac evaluation as part of transplant workup. |
Acceptable reference standard? All tests | Yes | Coronary angiography with a reference standard threshold of ≥ 70% stenosis. |
Acceptable delay between tests? All tests | Yes | Tests were done at the same time (author correspondence). |
Partial verification avoided? All tests | Yes | All participants who underwent the index test received the reference standard test. |
Differential verification avoided? All tests | Yes | Disease status (CAD) diagnosed by coronary angiography. |
Incorporation avoided? All tests | Yes | Disease status (CAD) diagnosed by coronary angiography. |
Reference standard results blinded? All tests | Yes | Angiograms were assessed by 2 cardiologists who were blinded to the perfusion imaging results. |
Index test results blinded? All tests | Yes | Images were assessed by nuclear cardiologists who were blinded to the cardiac catheterisation results. |
Relevant clinical information? All tests | Yes | Relevant clinical information was provided regarding the performance and analysis of the index and reference tests. |
Uninterpretable results reported? All tests | Yes | There were no uninterpretable test results. |
Withdrawals explained? All tests | Yes | No withdrawals reported. |
bpm: beats per minute; CAD: coronary artery disease; CF: cardiac failure; CHF: congestive heart failure; CIMT: carotid intimal medial thickness; CKD: chronic kidney disease; CVD: cardiovascular disease; DBP: diastolic blood pressure; DM: diabetes mellitus; DSE: dobutamine stress echocardiogram; DSTS: dipyridamole stress thallium scan; EBCT: electron beam computed tomography; ECG: electrocardiogram; ESKD: end‐stage kidney disease; HTN: hypertension; IHD: ischaemic heart disease; IMT: intimal media thickness; IV: intravenous; MI: myocardial infarction; MIBI: methoxyisobutyl isonitrile stress; MPS: myocardial perfusion scintigraphy; QCA: quantitative coronary analysis; RRT: renal replacement therapy; RWM: regional wall motion; SBP: systolic blood pressure; ST: sinus tachycardia; WMA: wall motion abnormality